Research Use
Also known as Pegylated Mechano-Growth Factor, IGF-1Ec

Function

Primary
Muscle repair (research)
Mechanism
PEGylated splice variant of IGF-1 (MGF / IGF-1Ec) — activates muscle satellite cells in response to mechanical loading; PEGylation extends half-life.
Evidence
Pre-clinical / Observational
Research
Pre-clinical only

Dosing

Range
100–200 mcg, 2–3×/week (anecdotal)
Frequency
Post-workout / multiple weekly
Route
Subcutaneous · Intramuscular

Administration & Technique

Local Injection
Post-workout, near trained muscle.
Device29–30G × 1/2" insulin syringe.
TechniqueSubQ directly over the target muscle within 30 min of training. 1–3× / week.

Injection & Application Sites

Front
Back
Local Injection
  • Over the target / injured muscleSubQ directly above the trained or injured muscle. Never intra-articular without imaging.

Diagram is a general illustration, not a medical instruction. Rotate sites every injection, keep 1 in (2.5 cm) between recent sites, and avoid scars, moles, bruises and the navel area.

Cycling

4–8 week cycles in user protocols.

Timing & Interactions

When to take
Post-workout only, injected locally near trained muscle groups. 1–3× per week on training days.
Do not combine with
  • ·Concurrent IGF-1 LR3 same site — additive mitogenic load
Complements
  • ·IGF-1 LR3 on alternate days
  • ·GH secretagogue stacks

Storage & Reconstitution

Powder (Pre-Reconstitution)
Lyophilized powder: refrigerate 2–8°C for up to 24 months, or freeze at –20°C for extended storage. Keep sealed, desiccated, and protected from light.
After Reconstitution
After reconstitution with bacteriostatic water, refrigerate at 2–8°C and use within 28 days. Discard if cloudy, discolored, or precipitated.
Notes
Do not freeze after reconstitution — freeze/thaw cycles degrade most peptides.
Full BAC water & reconstitution guide →

Reconstitution Calculator

Concentration
2.50 mg/mL
Volume per dose
0.100 mL
Insulin syringe
10.0 units (U-100)

1 mL = 100 units on a standard U-100 insulin syringe. Draw to the nearest 0.5 unit and confirm dosing with a clinician before injection.

Your Notes

Your Notes

Sign in to save personal notes on PEG-MGF and sync them to Vial Lab.

Benefits

  • ·Satellite cell activation
  • ·Localized hypertrophy / repair
  • ·Potential tendon repair

Risks

  • ·Hypoglycemia
  • ·Theoretical tumor promotion
  • ·Injection-site reactions

Contraindications

  • ·Cancer history
  • ·Pregnancy

Regulatory

Research chemical — banned by WADA

Veterinary Use (Pets)

Occasional use in equine sports medicine for post-injury local hypertrophy.

Horses (Equine)
Dose1–2 mg local SubQ over injured muscle 1–2× weekly
RouteLocal SubQ
UseMuscle/tendon rehab.
Prohibited in racing/FEI competition.
Full veterinary reference →

Cited Works

  1. Goldspink G. Mechano-Growth Factor: a target for hypertrophy & repair. J Musculoskelet Neuronal Interact. 2005;5:344.
Sign in to save favorites & stacks